MiroBio to be acquired by Gilead Sciences for $405M

https://www.gilead.com/news-and-press/press-room/press-releases/2022/8/gilead-sciences-to-acquire-mirobio

Previous
Previous

PsiOxus Therapetuics appoints Howard Davis as CEO

Next
Next

HotSpot Therapeutics appoints Paul Thibodeau as CBO